Compare Quest Diagnostics Inc (DGX) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Roblox Corp — how do they compare? Quest Diagnostics Inc trades at $205.48 (market cap $22.80B), while Roblox Corp trades at $55.6 (market cap $39.00B). The key difference: Roblox Corp is the larger of the two by market cap, and Quest Diagnostics Inc pays a 1.67% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| DGX | RBLX | |
|---|---|---|
Market Cap | $22.80B | $39.00B |
Sector | Health | Media |
52-Week High | $216.02 | $141.56 |
52-Week Low | $166.42 | $41.30 |
Enterprise Value | $28.82B | $37.59B |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
Roblox (RBLX) trades at $55.085, down 0.48% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $59.62. Revenue grew to $4.89 billion in 2025, though net losses persist at -$1.07 billion. The stock faces headwinds from multiple class-action lawsuits filed in July 2026 alleging securities fraud, but operational cash flow improved to $1.8 billion, supporting ongoing platform investments.
The outlook balances robust user growth and cash generation against profitability challenges and legal risks. Upside exists if monetization improves and legal issues resolve, but high P/B of 91.2 and negative margins warrant caution. Analysts remain predominantly bullish (51% buy ratings), viewing recent declines as a buying opportunity for long-term platform expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
